Lexeo Therapeutics LXEO
NASDAQ LXEO
$3.62 +0.24 (+7.10%)
At close: Oct 1, 2026 · 4:00 PM EDT

Lexeo Therapeutics (LXEO) Non Operating Income (2022 - 2026)

Updated

Lexeo Therapeutics (LXEO) reported Non Operating Income of $2.15 million for Q2 2026, down 53.0% from $4.59 million a year earlier but up 0.7% from the prior quarter.

Analysis

Lexeo Therapeutics (LXEO) Non Operating Income (2022 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Lexeo Therapeutics' Non Operating Income came in at $7.85 million, down 15.1% year-over-year; for FY2025, it was $9.3 million, up 25.1% from FY2024.

  • Non Operating Income has increased for three consecutive years, with a three-year compound annual growth rate of 96.1% (FY2022 to FY2025).
  • By year, Non Operating Income came in at $7.43 million in FY2024 (+250.8%), $2.12 million in FY2023 (+72.0%) and $1.23 million in FY2022.
  • Five-year quarterly Non Operating Income spans a low of $165,000 in Q3 2023 and a high of $4.59 million in Q2 2025.
  • Year over year, Non Operating Income gained in four of the last seven quarters, with growth averaging 29.3%.
  • The high point for year-over-year Non Operating Income in five years was Q2 2024 (growth of 333.0%); the low point was Q3 2023 (a decline of 61.4%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $2.14 million (Q1 2026), $2.2 million (Q4 2025) and $1.37 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -73.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 387.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Lexeo Therapeutics 265.74 Mn 265.74 Mn - 2.15 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.15 Mn
Mar 31, 2026 2.14 Mn
Dec 31, 2025 2.20 Mn
Sep 30, 2025 1.37 Mn
Jun 30, 2025 4.59 Mn
Mar 31, 2025 1.15 Mn
Dec 31, 2024 1.46 Mn
Sep 30, 2024 2.05 Mn
Jun 30, 2024 2.31 Mn
Mar 31, 2024 1.61 Mn
Dec 31, 2023 787,000.00
Sep 30, 2023 165,000.00
Jun 30, 2023 534,000.00
Mar 31, 2023 633,000.00
Dec 31, 2022 620,000.00
Sep 30, 2022 427,000.00
API Access

Lexeo Therapeutics Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=LXEO&period=max&api_key=YOUR_API_KEY